【IMPORTANT]】THE MARCH OPEN STUDY SESSION WILL BE HELD VIA ZOOM.
To whom it may concern
In order to prevent the spread of the new coronavirus both domestically and internationally,
a large scale of self-restraint is in place and educational institutions are closed.
We hope that everyone is in good health and that the situation is coming to an end.
In addition, due to a recommendation to refrain from various types of meetings,
the monthly open study sessions
will be held on the web via ZOOM for the month of March.
We will also be holding our monthly open study sessions on the web via ZOOM in March.
If you have any questions, please contact us.
◆_________◆
Intestinal Flora Transplantation Clinical Research Foundation
Secretariat
Tel: 06-6809-5296
E-mail : info@fmt-japan.org
◆_________◆
その他の Notices and Activity Reports に関する記事
Articles about other Notices and Activity Reports

November 16, 2026
10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]
The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 06, 2026
Survey Summary from the 10th Annual Academic Conference
The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

October 28, 2024
〈Clinical Trial〉Completion Report
We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]